DTC
MAZE

Deep Track Capital’s Maze Therapeutics MAZE Stock Holding History

Deep Track Capital’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111M Buy
3,732,569
+255,007
+7% +$6.68M 1.62% 26
2026
Q1 		$104M Sell
3,477,562
-768,878
-18% -$33.9M 1.7% 17
2025
Q4 		$176M Buy
4,246,440
+297,530
+8% +$10.2M 3.14% 11
2025
Q3 		$102M Hold
3,948,910
– – 2.86% 16
2025
Q2 		$48.5M Buy
3,948,910
+679,784
+21% +$7.07M 1.55% 21
2025
Q1 		$36M Buy
+3,269,126
New +$39.4M 1.17% 24

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Deep Track Capital's MAZE Position: Q2 2026 in Review

Deep Track Capital increased its Maze Therapeutics (MAZE) stake by 7.3% in Q2 2026, buying an estimated $6.68M and bringing the position to 3,732,569 shares worth $111M. The position accounts for 1.62% of the portfolio, ranked #26.

Deep Track Capital first reported a position in MAZE in Q1 2025 and has held it in 6 quarters since. The position peaked at $176M in Q4 2025. 161 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Deep Track Capital held 3,732,569 shares of Maze Therapeutics worth $111M as of Q2 2026.
  • Deep Track Capital bought 255,007 Maze Therapeutics shares in Q2 2026, an estimated $6.68M.
  • Maze Therapeutics made up 1.62% of Deep Track Capital's portfolio in Q2 2026, its #26 holding.
  • Deep Track Capital first reported a position in Maze Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Deep Track Capital's Maze Therapeutics position peaked at $176M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.